Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor)

Oncogene

Volumn 22, Issue 44, 2003, Pages 6873-6882

  Tolg, Cornelia ^a   Poon, Raymoond ^b   Fodde, Riccardo ^c   Turley, Eva Ann ^a   Alman, Benjamin Aaron ^b  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

catenin; Adenomatous polyposis coli; Aggressive fibromatosis; Density dependent proliferation; Hyaladherin; Rhamm; Transgenic mice

Indexed keywords

BETA CATENIN; CELL PROTEIN; HYALURONIC ACID; PROTEIN RHAMM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DESMOID TUMOR; FIBROMATOSIS; GENE DELETION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; TRANSGENIC MOUSE;

ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; ANTIGENS, CD44; CELL DIVISION; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; FIBROMATOSIS, AGGRESSIVE; GASTROINTESTINAL NEOPLASMS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; GENES, APC; GENETIC PREDISPOSITION TO DISEASE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; TUMOR CELLS, CULTURED;

ANIMALIA; MUS MUSCULUS;

EID: 0242406727     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206811     Document Type: Article

References (56)

1. Alman BA, Li C, Pajerski ME, Diaz-Cano S and Wolfe HJ. (1997b). Am. J. Pathol., 151, 329-334.
2. Alman BA, Pajerski ME, Diaz-Cano S, Corboy K and Wolfe HJ. (1997a). Diag. Mol. Pathol., 6, 98-101.
3. Assmann V, Jenkinson D, Marshall JF, Hart IR. (1999). J. Cell. Sci., 112, 3943-3954.
4. Assmann V, Gillett CE, Poulsom R, Ryder K, Hart IR and Hanby AM. (2001). J. Pathol., 195, 191-196.
5. Bissell MJ and Radisky D. (2001). Nat. Rev. Cancer, 1, 46-54.
6. Cheon SS, Cheah AY, Turley S, Nadesan P, Poon R, Clevers H and Alman BA. (2002). Proc. Natl. Acad. Sci. USA, 99, 6973-6978.
7. Cheung WF, Cruz TF and Turley EA. (1999). Biochem. Soc. Trans., 27, 135-142.
8. Crainie M, Belch AR, Mant MJ and Pilarski LM. (1999). Blood, 93, 1684-1696.
9. Duval A, Rolland S, Compoint A, Tubacher E, Iacopetta B, Thomas G and Hamelin R. (2001). Hum. Mol. Genet., 10, 513-518.
10. Fodde R, Edelmann W, Yang K, van Leeuwen C, Carlson C, Renault B, Breukel C, Alt E, Lipkin M and Khan PM. (1994). Proc. Natl. Acad. Sci. USA, 91, 8969-8973.
11. Gares SL and Pilarski LM. (2000). Dev. Immunol., 7, 209-225.
12. Gerdin B and Hallgren R. (1997). J. Intern. Med., 242, 49-55.
13. Gutierrez-Ruiz MC, Robles-Diaz G and Kershenobich D. (2002). Arch. Med. Res., 33, 595-599.
14. Hall CL, Lange LA, Prober DA, Zhang S and Turley EA. (1996). Oncogene, 13, 2213-2224.
15. Hall CL, Yang B, Yang X, Zhang S, Turley M, Samuel S, Lange LA, Wang C, Curpen GD, Savani RC, Greenberg AH and Turley EA. (1995). Cell, 82, 19-26.
16. Hardwick C, Hoare K, Owens R, Hohn HP, Hook M, Moore D, Cripps V, Austen L, Nance DM and Turley EA. (1992). J. Cell. Biol., 117, 1343-1350.
17. Hopyan S, Gokgoz N, Bell RS, Andrulis IL, Alman BA and Wunder JS. (1999). J. Orthop. Res., 17, 633-638.
18. Kong QY, Liu J, Chen XY, Wang XW, Sun Y and Li H. (2003). Oncol. Rep., 10, 51-55.
19. Li C, Bapat B and Alman BA. (1998). Am. J. Pathol., 153, 709-714.
20. Li H, Guo L, Li JW, Liu N, Qi R and Liu J. (2000). Int. J. Oncol., 17, 927-932.
21. Line A, Slucka Z, Stengrevics A, Silina K, Li G and Rees RC. (2002). Cancer Immunol. Immunother., 51, 574-582.
22. Lokeshwar VB and Selzer MG. (2000). J. Biol. Chem., 275, 27641-27649.
23. Lovvorn III HN, Cass DL, Sylvester KG, Yang EY, Crombleholme TM, Adzick NS and Savani RC. (1998). J. Pediatr. Surg., 33, 1062-1069.
24. Lynn BD, Li X, Cattini PA, Turley EA and Nagy JI. (2001). J. Comp. Neurol., 439, 315-330.
25. Miller JR, Hocking AM, Brown JD and Moon RT. (1999). Oncogene, 18, 7860-7872.
26. Mohapatra S, Yang X, Wright JA, Turley EA and Greenberg AH. (1996). J. Exp. Med., 183, 1663-1668.
27. Naor D, Sionov RV, Zahalka M, Rochman M, Holzmann B and Ish-Shalom D. (1998). Curr. Top. Microbiol. Immunol., 231, 143-166.
28. Pear W, Nolan GP, Scott M and Baltimore D. (1993). Proc. Natl. Acad. Sci. USA, 90, 8392-8396.
29. Pilarski LM, Masellis-Smith A, Belch AR, Yang B, Savani RC and Turley EA. (1994). Leuk. Lymphoma, 14, 363-374.
30. Ponta H, Sherman L and Herrlich PA. (2003). Nat. Rev. Mol. Cell. Biol., 4, 33-45.
31. Poon R, Smits R, Li C, Jagmohan-Changur S, Kong M, Cheon S, Yu C, Fodde R and Alman BA. (2001). Oncogene, 20, 451-460.
32. Roose J and Clevers H. (1999). Biochim. Biophys. Acta, 1424, M23-M37.
33. Savanger P. (2001). BioEssays, 23, 912-923.
34. Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z and DeLisser HM. (2001). J. Biol. Chem., 276, 36770-36778.
35. Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, Wight TN, Stern R, Nance DM and Turley EA. (1995). J. Clin. Invest., 95, 58-68.
36. Sivaraman VS, Wang H, Nuovo GJ and Malbon CC. (1997). J. Clin. Invest., 99, 1478-1483.
37. Smits R, van der Houven van Oordt W, Luz A, Zurcher C, Jagmohan-Changur S, Bruekel C, Khan PM and Fodde R. (1998). Gastroenterology, 114, 275-283.
38. Spicer AP, Roller ML, Camper SA, McPherson JD, Wasmuth JJ, Hakim S, Wang C, Turley EA and McDonald JA. (1995). Genomics, 30, 115-117.
39. Tammi MI, Day AJ and Turley EA. (2002). J. Biol. Chem., 277, 4581-4584.
40. Tejpar S, Li C, Yu C, Poon R, Denys H, Sciot R, Van Cutsem E, Cassiman JJ and Alman BA. (2001). Br. J. Cancer, 85, 98-101.
41. Tejpar S, Nollet F, Li C, Wunder JS, Michils G, dal Cin P, Van Cutsem E, Bapat B, van Roy F, Cassiman JJ and Alman BA. (1999). Oncogene, 18, 6615-6620.
42. Toole BP. (2002). Glycobiology, 12, 37R-42R.
43. Turley EA. (1982). Biochem. Biophys. Res. Commun., 188, 1016-1024.
44. Turley E and Auersperg N. (1989). Exp. Cell. Res., 182, 340-348.
45. Turley EA, Austen L, Vandeligt K and Clary C. (1991). J. Cell. Biol., 112, 1041-1047.
46. Turley EA, Bowman P and Kytryk MA. (1985). J. Cell. Sci., 78, 133-145.
47. Turley EA, Brassel P and Moore D. (1990). Exp. Cell Res., 187, 243-249.
48. Turley EA, Noble PW and Bourguignon LY. (2002). J. Biol. Chem., 277, 4589-4592.
49. van der Houven van Oordt CW, Smits R, Schouten TG, Houwing-Duistermaat JJ, Williamson SL, Luz A, Meera Khan P, Van der Eb AJ, Breuer ML and Fodde R. (1999). Genes Chromosom. Cancer, 24, 191-198.
50. van der Lugt N, Maandag ER, te Riele H, Laird PW and Berns A. (1991). Gene, 105, 263-267.
51. Wang C, Thor AD, Moore II DH, Zhao Y, Kerschmann R, Stern R, Watson PH and Turley EA. (1998). Clin. Cancer Res., 4, 567-576.
52. Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H and Pals ST. (1999). Am. J. Pathol., 154, 515-523.
53. Wong NA and Pignatelli M. (2002). Am. J. Pathol., 160, 389-401.
54. Yang B, Yang BL, Savani RC and Turley EA. (1994). EMBO J., 13, 286-296.
55. Zhang S, Chang MC, Zylka D, Turley S, Hanson R and Turley EA. (1998). J. Biol. Chem., 273, 11342-11348.
56. Zhou R, Wu X and Skalli O. (2002). J. Neurooncol., 59, 15-26.